Progestin or anti-estrogen treatment for endometrial cancer: choosing the best option for selected patients.
- Resource Type
- Article
- Authors
- Caretto, Marta; Simoncini, Tommaso
- Source
- Gynecological Endocrinology. Nov 2021, Vol. 37 Issue 11, p959-960. 2p.
- Subject
- *ENDOMETRIAL cancer
*LOW-molecular-weight heparin
*PRECOCIOUS puberty
*LEVONORGESTREL intrauterine contraceptives
*HORMONE receptor positive breast cancer
*CANCER treatment
*CANCER
- Language
- ISSN
- 0951-3590
Hormonal therapy in endometrial cancer (EC) is an alternative treatment for women with metastatic or recurrent disease without curative options [[1]] and a strong desire to preserve their fertility. Treatment with tamoxifen or the combination of tamoxifen and progestin could be a first choice in anti-estrogen therapy for patients with advanced and recurrent EC. [Extracted from the article]